Table 1.

STAT3 expression in relation to clinicopathologic variables

STAT3 expression123P
Age (y)
    <5016 (26.23%)29 (47.54%)16 (26.23%)0.881
    ≥509 (21.95%)21 (51.22%)11 (26.83%)
Estrogen receptor status
    Negative18 (28.57%)31 (49.21%)14 (22.22%)0.327
    Positive7 (17.95%)19 (48.72%)13 (33.33%)
Histologic grading
    13 (23.08%)5 (38.46%)5 (38.46%)0.861
    215 (25.42%)29 (49.15%)15 (25.42%)
    37 (23.33%)16 (53.33%)7 (23.33%)
Primary tumor staging
    T17 (35.00%)9 (25.00%)5 (25.00%)0.871
    T213 (24.53%)26 (49.06%)14 (26.42%)
    T42 (22.22%)4 (44.44%)3 (33.33%)
Lymph node status
    N014 (29.16%)21 (43.75%)13 (27.09%)0.113
    N12 (10.53%)15 (78.94%)2 (10.53%)
    N25 (22.73%)8 (36.36%)9 (40.91%)
    N34 (30.77%)6 (46.15%)3 (23.08%)
TNM staging
    I4 (30.77%)5 (38.46%)4 (30.77%)0.619
    II10 (21.28%)27 (57.45%)10 (21.28%)
    III11 (26.19%)18 (42.86%)13 (30.95%)